1. Cyclophosphamide alters the tumor cell secretome to potentiate the anti-myeloma activity of daratumumab through augmentation of macrophage-mediated antibody dependent cellular phagocytosis. (1st January 2021) Authors: Naicker, Serika D; Feerick, Claire L; Lynch, Kevin; Swan, Dawn; McEllistrim, Cian; Henderson, Robert; Leonard, Niamh A; Treacy, Oliver; Natoni, Alessandro; Rigalou, Athina; Cabral, Joana; Chiu, Christopher; Sasser, Kate; Ritter, Thomas; O'Dwyer, Michael; Ryan, Aideen E Journal: Oncoimmunology Issue: Volume 10:Number 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗